Results 41 to 50 of about 102 (72)
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Am J Nephrol, 2019 Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G, on behalf of the FIDELIO-DKD study investigators, FIDELIO-DKD study investigators. +11 moreeuropepmc +1 more sourceISARIC COVID-19 Clinical Data Report: Final report January 2020 – January 2023
, 2020 ISARIC Clinical Characterisation Group, Baillie JK, Baruch J, Beane A, Blumberg L, Bozza FA, Broadley T, Broadley T, Burrell A, Burrell A, Carson G, Citarella BW, Dunning J, Elotmani L, Garcia Barrio N, Garcia Barrio N, Goffard J, Hall M, Hall M, Hashmi M, Horby P, Jassat W, Kartsonaki C, Kumar Tirupakuzhi Vijayaraghavan B, Kumar Vecham P, Laouenan C, Lissauer S, Lissauer S, Martin-Loeches I, Martin-Loeches I, Mentre F, Morton B, Munblit D, Nekliudov NA, Nichol A, Ong DS, Panda PK, Jimenez MP, Petrovic M, Ramakrishnan N, Ramos GV, Roger C, Rojek A, Sandulescu O, Semple MG, Sharma P, Shrapnel S, Sigfrid L, Sim Lim Heng B, Singh BC, Somers E, Streinu-Cercel A, Taccone FS, Wei J, Wils E, Wong XC, Young K, Olliaro PL, Merson L. +58 moreeuropepmc +1 more source